retatrutide ly3437943 glp-1 gip glucagon in healthy participants in a phase 1 single ascending dose Structural insights into the triple

7 In particular, weight loss induced by GLP-1 RAs has been associated with significant improvement in debilitating headaches, especially in conditions such as idiopathic intracranial hypertension (IIH) and migraine, both of which are known to be exacerbated by obesity and its associated systemic inflammation

For now, Williams is taking the weekly GLP-1 injections and trains for a half-marathon (13.1 miles)

Bone Health Implications Menopause accelerates bone loss, making osteoporosis prevention a priority for many women

Retatrutide is not currently available in the UK as a licensed weight loss treatment

My take: GLP-1RAs may become more than metabolic drugs, but oncology needs prospective cancer-outcome data before calling this prevention

Before starting the therapy, the patients are screened to determine possible contraindications according to the medical history and existing medications